| Ms Danielle Knight, APN-C | |
|
11 Overlook Road, Mac Ii Building, Suite Ll 101, Summit, NJ 07901 | |
| (908) 522-5900 | |
| (908) 522-5544 |
| Full Name | Ms Danielle Knight |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 11 Overlook Road, Summit, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013561190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | 26NJ00938300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlook Medical Center | Summit, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Today at the American Health Information Management Association's Computer-Assisted Coding Summit, Dolbey announced that it has completed, along with Artificial Medical Intelligence, the first phase of its Fusion CAC implementation at Adventist Health System in Orlando, Florida.
Salmonella enterica, one of the main causes of gastrointestinal infections, modulates its virulence gene expression, adapting it to each stage of the infection process, depending on the free iron concentration found in the intestinal epithelium of its host.
When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.
The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 7 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Today at the American Health Information Management Association's Computer-Assisted Coding Summit, Dolbey announced that it has completed, along with Artificial Medical Intelligence, the first phase of its Fusion CAC implementation at Adventist Health System in Orlando, Florida.
Salmonella enterica, one of the main causes of gastrointestinal infections, modulates its virulence gene expression, adapting it to each stage of the infection process, depending on the free iron concentration found in the intestinal epithelium of its host.
When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.
The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Danielle Knight, APN-C Po Box 416457, Boston, MA 02241-6457 Ph: (844) 362-1735 | Ms Danielle Knight, APN-C 11 Overlook Road, Mac Ii Building, Suite Ll 101, Summit, NJ 07901 Ph: (908) 522-5900 |
News Archive
Today at the American Health Information Management Association's Computer-Assisted Coding Summit, Dolbey announced that it has completed, along with Artificial Medical Intelligence, the first phase of its Fusion CAC implementation at Adventist Health System in Orlando, Florida.
Salmonella enterica, one of the main causes of gastrointestinal infections, modulates its virulence gene expression, adapting it to each stage of the infection process, depending on the free iron concentration found in the intestinal epithelium of its host.
When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.
The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 7 days ago
Cynthia E Cross, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 973-971-5595 | |
Elfie Wegner, RN P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Summit, NJ 07901 Phone: 973-971-7184 | |
Darnell Hassan Stith Jr., APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Amy Lynne Ishak, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-5310 | |
Sarah Barnett, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Springfield Ave, Pulmonary And Allergy Associates, Summit, NJ 07901 Phone: 908-934-0555 Fax: 908-934-0558 | |
Jennifer Lillian O'neill, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 33 Overlook Rd Ste 201, Summit, NJ 07901 Phone: 908-522-5040 Fax: 908-522-5041 |